Keywords: mmrc, keryx, initiate, ph, krx-0401, study, usa-based

MMRC and Keryx initiate Ph I KRX-0401 study

Article | 08 January 2007

The USA-based Multiple Myeloma Research Consortium and Keryx Biopharmaceuticals have initiated a multicenter Phase I clinical program to explore the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

lenalidomide

Revlimid

Nystatin

Go to drug listing